Ra Medical Systems’ Catheter Precision announces publication of VIVO data

Ra Medical Systems announced that its wholly owned subsidiary, Catheter Precision, Inc., has had new clinical data published for its leading product VIVO, that confirms the perceived benefits of using VIVO in a ventricular ablation program. VIVO is a non-invasive localization system that provides the physician with data about the patient’s heart prior to a ventricular ablation. This data is then used by the physician to plan certain aspects of the procedure including where to look for the start of the arrhythmia, which can be a time-consuming process. The newest publication by the Royal Brompton Hospital with lead author Professor Sabine Ernst, confirms that VIVO does reduce mapping time by almost 30%. A reduction in mapping time leads to a total reduction in procedure time, potentially increasing patient safety. In addition, this publication discusses that patients with previous ablations that were unable to be performed were now able to have successful ablation procedures improving treatment options for patients with infrequent ventricular arrhythmias.